Sinovac Gets $9.6 Million China Grant To Build EV71 Vaccine Plant
This article was originally published in PharmAsia News
Executive Summary
A China agency has awarded a $9.6 million grant to Sinovac Biotech to build a plant to produce the company’s enterovirus 71 vaccine for preventing hand, foot and mouth disease.